Markus Schmutz

4.1k total citations
53 papers, 2.7k citations indexed

About

Markus Schmutz is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Markus Schmutz has authored 53 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 17 papers in Psychiatry and Mental health. Recurrent topics in Markus Schmutz's work include Neuroscience and Neuropharmacology Research (36 papers), Epilepsy research and treatment (17 papers) and Ion channel regulation and function (12 papers). Markus Schmutz is often cited by papers focused on Neuroscience and Neuropharmacology Research (36 papers), Epilepsy research and treatment (17 papers) and Ion channel regulation and function (12 papers). Markus Schmutz collaborates with scholars based in Switzerland, United States and Germany. Markus Schmutz's co-authors include C. Portet, H.‐R. Olpe, K. Klebs, Hans Allgeier, H.-R. Olpe, Michael J. McLean, Yves P. Auberson, P. C. Waldmeier, Serge Bischoff and Robert Moretti and has published in prestigious journals such as Journal of Neuroscience, Neurology and Neuroscience.

In The Last Decade

Markus Schmutz

52 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Schmutz Switzerland 26 1.8k 1.1k 745 430 358 53 2.7k
L. Turski Poland 29 2.4k 1.3× 1.0k 1.0× 963 1.3× 441 1.0× 503 1.4× 57 3.1k
Harold H. Wolf United States 21 1.7k 0.9× 1.0k 1.0× 1.1k 1.5× 574 1.3× 171 0.5× 62 2.8k
Zdzisław Kleinrok Poland 24 1.6k 0.9× 746 0.7× 1.1k 1.4× 438 1.0× 242 0.7× 63 2.2k
Wolfgang Löscher Germany 23 1.4k 0.7× 563 0.5× 937 1.3× 566 1.3× 168 0.5× 32 2.3k
Janet L. Stringer United States 33 2.4k 1.3× 1.6k 1.5× 929 1.2× 221 0.5× 854 2.4× 88 3.5k
Manfred Karobath Austria 33 2.0k 1.1× 1.4k 1.3× 299 0.4× 165 0.4× 249 0.7× 74 2.7k
Dagmar Hönack Germany 30 2.3k 1.3× 1.0k 1.0× 1.5k 2.1× 954 2.2× 273 0.8× 48 3.1k
Peter D. Suzdak Denmark 36 4.0k 2.2× 2.6k 2.4× 564 0.8× 300 0.7× 598 1.7× 87 5.2k
Luísa Rocha Mexico 26 1.5k 0.8× 643 0.6× 712 1.0× 348 0.8× 500 1.4× 147 2.5k
T. A. Branchek United States 25 2.1k 1.2× 1.8k 1.7× 408 0.5× 137 0.3× 168 0.5× 32 3.3k

Countries citing papers authored by Markus Schmutz

Since Specialization
Citations

This map shows the geographic impact of Markus Schmutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Schmutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Schmutz more than expected).

Fields of papers citing papers by Markus Schmutz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Schmutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Schmutz. The network helps show where Markus Schmutz may publish in the future.

Co-authorship network of co-authors of Markus Schmutz

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Schmutz. A scholar is included among the top collaborators of Markus Schmutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Schmutz. Markus Schmutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connor, Richard M., Deepak R. Thakker, Markus Schmutz, et al.. (2013). Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse. Neuropharmacology. 72. 66–73. 27 indexed citations
2.
Koller, Manuel, Kurt Lingenhoehl, Markus Schmutz, et al.. (2011). Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3358–3361. 33 indexed citations
3.
Hoyer, Daniël, Deepak R. Thakker, François Natt, et al.. (2006). Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders. Journal of Receptors and Signal Transduction. 26(5-6). 527–547. 19 indexed citations
4.
Hoyer, Daniël, Markus Schmutz, Ron Maier, et al.. (2005). mGluR7 plays a key role in the modulation of anxiety behavior: Evidence from mGluR7-knockout mice and siRNA-induced knockdown in the adult mouse brain. Neuropharmacology. 49. 3 indexed citations
5.
Kaupmann, Klemens, John F. Cryan, Petrine Wellendorph, et al.. (2003). Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABAB(1)‐deficient mice. European Journal of Neuroscience. 18(10). 2722–2730. 152 indexed citations
6.
Auberson, Yves P., Hans Allgeier, Serge Bischoff, et al.. (2002). 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorganic & Medicinal Chemistry Letters. 12(7). 1099–1102. 188 indexed citations
7.
Ametamey, Simon M., Peter Bläuenstein, Serge Bischoff, et al.. (2000). Synthesis, radiolabelling and biological characterization of (d)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors. Bioorganic & Medicinal Chemistry Letters. 10(1). 75–78. 9 indexed citations
8.
Gasparini, F., Valeria Bruno, Giuseppe Battaglia, et al.. (1999). (R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1678–1687. 143 indexed citations
9.
Acklin, Pierre, Hans Allgeier, Yves P. Auberson, et al.. (1998). 5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 493–498. 21 indexed citations
10.
Waldmeier, P. C., et al.. (1996). Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(2). 164–72. 64 indexed citations
11.
Schmutz, Markus, Felix Brugger, C. Gentsch, Michael J. McLean, & H.‐R. Olpe. (1994). Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of Action. Epilepsia. 35(s5). S47–50. 89 indexed citations
12.
McLean, Michael J., et al.. (1994). Oxcarbazepine: Mechanisms of Action. Epilepsia. 35(s3). S5–9. 116 indexed citations
13.
Klebs, K., et al.. (1992). Blockade of GABAB receptors accelerates amygdala kindling development. Cellular and Molecular Life Sciences. 48(8). 748–751. 16 indexed citations
14.
Schmutz, Markus, K. Klebs, A. Vassout, et al.. (1990). The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 61–66. 126 indexed citations
15.
Bernasconi, R., Marianne Klein, Pierre Martin, et al.. (1988). ?-Vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice. Journal of Neural Transmission. 72(3). 213–233. 92 indexed citations
16.
Bernasconi, R., Christian Marescaux, M. Vergnes, et al.. (1988). Evaluation of the anticonvulsant and biochemical activity of CGS 8216 and CGS 9896 in animal models. Journal of Neural Transmission. 71(1). 11–27. 8 indexed citations
17.
Schmutz, Markus, K. Klebs, & V. Baltzer. (1988). Inhibition or enhancement of kindling evolution by antiepileptics. Journal of Neural Transmission. 72(3). 245–257. 62 indexed citations
18.
Steinmann, Martin W., et al.. (1988). Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(6). 655–657. 20 indexed citations
19.
Schmutz, Markus. (1987). Relevance of kindling and related processes to human epileptogenesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 11(4). 505–525. 25 indexed citations
20.
Kerwin, R., H.-R. Olpe, & Markus Schmutz. (1980). THE EFFECT OF SODIUM‐n‐DIPROPYL ACETATE ON γ‐AMINOBUTYRIC ACID‐DEPENDENT INHIBITION IN THE RAT CORTEX AND SUBSTANTIA NIGRA IN RELATION TO ITS ANTICONVULSANT ACTIVITY. British Journal of Pharmacology. 71(2). 545–551. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Turski Breakdown of academic impact, for papers by Harold H. Wolf Breakdown of academic impact, for papers by Zdzisław Kleinrok Breakdown of academic impact, for papers by Wolfgang Löscher Breakdown of academic impact, for papers by Janet L. Stringer Breakdown of academic impact, for papers by Manfred Karobath Breakdown of academic impact, for papers by Dagmar Hönack Breakdown of academic impact, for papers by Peter D. Suzdak Breakdown of academic impact, for papers by Luísa Rocha Breakdown of academic impact, for papers by T. A. Branchek
Rankless by CCL
2026